檢索結果 - Sevil Korkmaz‐Icöz
- Showing 1 - 3 results of 3
-
1
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus 由 Csaba Mátyás, Balázs Tamás Németh, Attila Oláh, László Hidi, Ede Birtalan, Dalma Kellermayer, Mihály Ruppert, Sevil Korkmaz‐Icöz, Gábor Kökény, E Horváth, Gábor Szabó, Béla Merkely, Tamás Radovits
出版 2015Artigo -
2
Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation 由 Alex Ali Sayour, Sevil Korkmaz‐Icöz, Sivakkanan Loganathan, Mihály Ruppert, Nabil V. Sayour, Attila Oláh, Kálmán Benke, Maik Brune, Rita Benkő, E Horváth, Matthias Karck, Béla Merkely, Tamás Radovits, Gábor Szabó
出版 2019Artigo -
3
Critical role of RAGE and HMGB1 in inflammatory heart disease 由 Anna Bangert, Martin Andrassy, Anna‐Maria Müller, Mariella Bockstahler, Andrea Fischer, Christian Volz, Christoph Leib, Stefan Göser, Sevil Korkmaz‐Icöz, Stefan Zittrich, Andreas Jungmann, Felix Lasitschka, Gabriele Pfitzer, Oliver J. Müller, Hugo A. Katus, Ziya Kaya
出版 2015Artigo
相關主題
Internal medicine
Medicine
Cardiology
Diabetes mellitus
Endocrinology
Receptor
Activator (genetics)
Anesthesia
Angiology
Biology
Canagliflozin
Cardiomyopathy
Cardioprotection
Disease
Enos
GUCY1A3
GUCY1B3
Glycation
Guanylate cyclase
Guanylate cyclase 2C
HMGB1
Heart failure
Immune system
Immunity
Immunology
Inflammation
Ischemia
Myocarditis
Neuroscience
Nitric oxide